Literature DB >> 2242428

Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.

L J Medeiros1, J H Van Krieken, E S Jaffe, M Raffeld.   

Abstract

Previous studies using classical cytogenetics have demonstrated the presence of the t(11;14) (q13;q32) chromosomal translocation in some cases of lymphocytic lymphoma of intermediate differentiation (IDL), a distinct type of low grade B-cell lymphoma. This finding suggested that the bcl-1 region (located at band q13 of chromosome 11) might be involved in this neoplasm. Using a genomic probe from the major breakpoint area of the bcl-1 locus, we identified rearrangements of the bcl-1 region in 10 of 19 cases, 2 of which comigrated with a rearranged allele of the immunoglobulin heavy chain gene joining region. In contrast, bcl-1 rearrangements were not found in other types of low grade B-cell lymphoma, specifically in 36 cases of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and 27 cases of follicular lymphoma (FL). To further assess the molecular pathology of IDL, we analyzed these cases for rearrangements of the bcl-2 proto-oncogene, which is associated primarily with follicular lymphomas. None of the 19 cases of IDL had rearrangements. Furthermore, none of the 36 cases of CLL/SLL showed bcl-2 rearrangements, whereas, as expected, 21 of 27 cases of FL had rearrangements of the bcl-2 locus. Our findings demonstrate an association between a rearranged bcl-1 region with approximately 50% of IDLs and suggest that abnormalities of this locus may be important in the pathogenesis of IDL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2242428

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  17 in total

Review 1.  The molecular biology of B-cell lymphoma: clinicopathologic implications.

Authors:  P M Kluin; J H van Krieken
Journal:  Ann Hematol       Date:  1991-04       Impact factor: 3.673

Review 2.  Molecular pathology of low grade malignant lymphomas.

Authors:  H Ratech
Journal:  Med Oncol       Date:  1995-09       Impact factor: 3.064

3.  Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.

Authors:  Vilmos A Thomázy; Rajyalakshmi Luthra; Margaret O Uthman; Peter J A Davies; L Jeffrey Medeiros
Journal:  J Mol Diagn       Date:  2002-11       Impact factor: 5.568

Review 4.  Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms.

Authors:  Arantza Onaindia; L Jeffrey Medeiros; Keyur P Patel
Journal:  Mod Pathol       Date:  2017-06-30       Impact factor: 7.842

5.  Expression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activity.

Authors:  P Jares; E Campo; M Pinyol; F Bosch; R Miquel; P L Fernandez; M Sanchez-Beato; F Soler; A Perez-Losada; I Nayach; C Mallofré; M A Piris; E Montserrat; A Cardesa
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

6.  Activation of mammalian target of rapamycin signaling promotes cell cycle progression and protects cells from apoptosis in mantle cell lymphoma.

Authors:  Evangelia Peponi; Elias Drakos; Guadalupe Reyes; Vasiliki Leventaki; George Z Rassidakis; L Jeffrey Medeiros
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

7.  PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma.

Authors:  C L Rosenberg; E Wong; E M Petty; A E Bale; Y Tsujimoto; N L Harris; A Arnold
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

8.  Immunophenotyping by flow cytometry of fine needle aspirates in the diagnosis of lymphoproliferative disorders: A retrospective study.

Authors:  R M Henrique; M E Sousa; M I Godinho; I Costa; I L Barbosa; C A Lopes
Journal:  J Clin Lab Anal       Date:  1999       Impact factor: 2.352

9.  8-Aminoadenosine inhibits Akt/mTOR and Erk signaling in mantle cell lymphoma.

Authors:  Jennifer B Dennison; Mala Shanmugam; Mary L Ayres; Jun Qian; Nancy L Krett; L Jeffrey Medeiros; Sattva S Neelapu; Steven T Rosen; Varsha Gandhi
Journal:  Blood       Date:  2010-09-15       Impact factor: 22.113

10.  Cyclin D1 (Bcl-1, PRAD1) protein expression in low-grade B-cell lymphomas and reactive hyperplasia.

Authors:  W I Yang; L R Zukerberg; T Motokura; A Arnold; N L Harris
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.